| | | | | | | | | | | | | | | | |
| |
![Collapse](/DXR.axd?r=1_87-p7f1t) | Issue Date FY: 2024 ( Subtotal = $71,164,589 ) (Continued on the next page) |
| 2024 | 2024 | UNIVERSITY OF MISSOURI SYSTEM | 121 UNIVERSITY HALL | COLUMBIA | MO | 65211-3020 | BOONE | USA | R01EY031674 | Gene therapy for preserving the visual system in lysosomal storage diseases | 000 | 4 | NIH | 3/13/2024 | $382,470 |
| 2024 | 2024 | UNIVERSITY OF MISSOURI SYSTEM | 121 UNIVERSITY HALL | COLUMBIA | MO | 65211-3020 | BOONE | USA | R01DE029833 | Targeting P2 Receptors to Restore Salivary and Lacrimal Gland Function in Sjogren's Syndrome | 002 | 4 | NIH | 6/10/2024 | $47,569 |
| 2024 | 2024 | UNIVERSITY OF MISSOURI SYSTEM | 121 UNIVERSITY HALL | COLUMBIA | MO | 65211-3020 | BOONE | USA | R01DE029833 | Targeting P2 Receptors to Restore Salivary and Lacrimal Gland Function in Sjogren's Syndrome | 000 | 4 | NIH | 2/20/2024 | $535,140 |
| 2024 | 2024 | UNIVERSITY OF MISSOURI SYSTEM | 121 UNIVERSITY HALL | COLUMBIA | MO | 65211-3020 | BOONE | USA | R01DE029833 | Targeting P2 Receptors to Restore Salivary and Lacrimal Gland Function in Sjogren's Syndrome | 001 | 4 | NIH | 2/27/2024 | $59,659 |
| 2024 | 2024 | UNIVERSITY OF MISSOURI SYSTEM | 121 UNIVERSITY HALL | COLUMBIA | MO | 65211-3020 | BOONE | USA | R01AI153076 | Regulation of host immunity to impact virus persistence | 000 | 4 | NIH | 6/4/2024 | $410,491 |
| 2024 | 2024 | UNIVERSITY OF MISSOURI SYSTEM | 121 UNIVERSITY HALL | COLUMBIA | MO | 65211-3020 | BOONE | USA | R01DE029808 | MINE-MS for horizontal bone loss treatment | 001 | 4 | NIH | 4/8/2024 | $319,842 |
| 2024 | 2024 | UNIVERSITY OF MISSOURI SYSTEM | 121 UNIVERSITY HALL | COLUMBIA | MO | 65211-3020 | BOONE | USA | R01HL149727 | Glutaminase in Arterial Injury and Disease | 000 | 4 | NIH | 5/16/2024 | $390,685 |
| 2024 | 2024 | UNIVERSITY OF MISSOURI SYSTEM | 121 UNIVERSITY HALL | COLUMBIA | MO | 65211-3020 | BOONE | USA | R01HL153264 | Role of neuraminidase activity on endothelial dysfunction in type 2 diabetes | 000 | 4 | NIH | 5/17/2024 | $646,166 |
| 2024 | 2024 | UNIVERSITY OF MISSOURI SYSTEM | 121 UNIVERSITY HALL | COLUMBIA | MO | 65211-3020 | BOONE | USA | R01HD102476 | Functional characterization of mesenchymal-epithelial transition (MET)-derived cells in normal endometrial regeneration | 000 | 4 | NIH | 5/13/2024 | $322,101 |
| 2024 | 2024 | UNIVERSITY OF MISSOURI SYSTEM | 121 UNIVERSITY HALL | COLUMBIA | MO | 65211-3020 | BOONE | USA | R01HL151384 | Targeting ADAM17 activity for correction of vascular insulin resistance in type 2 diabetes | 001 | 4 | NIH | 6/21/2024 | $54,523 |
| 2024 | 2024 | UNIVERSITY OF MISSOURI SYSTEM | 121 UNIVERSITY HALL | COLUMBIA | MO | 65211-3020 | BOONE | USA | R01HL151384 | Targeting ADAM17 activity for correction of vascular insulin resistance in type 2 diabetes | 000 | 4 | NIH | 2/26/2024 | $613,392 |
| 2024 | 2024 | UNIVERSITY OF MISSOURI SYSTEM | 121 UNIVERSITY HALL | COLUMBIA | MO | 65211-3020 | BOONE | USA | K08AA028543 | The College Alcohol Intervention Matrix (College AIM): Adoption and Implementation Across College Campuses | 000 | 4 | NIH | 6/13/2024 | $164,039 |
| 2024 | 2024 | UNIVERSITY OF MISSOURI SYSTEM | 121 UNIVERSITY HALL | COLUMBIA | MO | 65211-3020 | BOONE | USA | R01HL157038 | Role of sensory nerves in perivascular inflammation and vasomotor dysfunction with inflammatory bowel disease | 000 | 4 | NIH | 3/1/2024 | $377,125 |
| 2024 | 2024 | UNIVERSITY OF MISSOURI SYSTEM | 121 UNIVERSITY HALL | COLUMBIA | MO | 65211-3020 | BOONE | USA | R01DK124329 | Endothelial mineralocorticoid receptors in diet-induced skeletal muscle insulin resistance | 001 | 4 | NIH | 5/3/2024 | $23,064 |
| 2024 | 2024 | UNIVERSITY OF MISSOURI SYSTEM | 121 UNIVERSITY HALL | COLUMBIA | MO | 65211-3020 | BOONE | USA | R01DK124329 | Endothelial mineralocorticoid receptors in diet-induced skeletal muscle insulin resistance | 000 | 4 | NIH | 11/22/2023 | $345,973 |
| 2024 | 2024 | UNIVERSITY OF MISSOURI SYSTEM | 121 UNIVERSITY HALL | COLUMBIA | MO | 65211-3020 | BOONE | USA | R01CA247763 | Targeting tumor and its microenvironment using nanotherapeutics for pancreatic cancer | 002 | 5 | NIH | 5/15/2024 | $355,739 |
| 2024 | 2024 | UNIVERSITY OF MISSOURI SYSTEM | 121 UNIVERSITY HALL | COLUMBIA | MO | 65211-3020 | BOONE | USA | R01HL159157 | Neuroendocrine dysfunction and hypertension | 000 | 4 | NIH | 6/28/2024 | $537,339 |
| 2024 | 2024 | UNIVERSITY OF MISSOURI SYSTEM | 121 UNIVERSITY HALL | COLUMBIA | MO | 65211-3020 | BOONE | USA | R01AI152418 | Vaccines Against Ehrlichia and Anaplasma Species Infections | 002 | 5 | NIH | 5/15/2024 | $598,826 |
| 2024 | 2024 | UNIVERSITY OF MISSOURI SYSTEM | 121 UNIVERSITY HALL | COLUMBIA | MO | 65211-3020 | BOONE | USA | R01AR078045 | EphA7 promotes contact-dependent myogenesis | 000 | 5 | NIH | 6/4/2024 | $316,390 |
| 2024 | 2024 | UNIVERSITY OF MISSOURI SYSTEM | 121 UNIVERSITY HALL | COLUMBIA | MO | 65211-3020 | BOONE | USA | R01HD101243 | Molecular mechanisms of endometrial progesterone resistance | 000 | 6 | NIH | 5/2/2024 | $509,548 |
| 2024 | 2024 | UNIVERSITY OF MISSOURI SYSTEM | 121 UNIVERSITY HALL | COLUMBIA | MO | 65211-3020 | BOONE | USA | R01HL152288 | Hyperpolarized xenon MRI in treatment of severe asthma by mepolizumab: toward earlier detection of individual patient responses | 001 | 5 | NIH | 7/23/2024 | $387,500 |
| 2024 | 2024 | UNIVERSITY OF MISSOURI SYSTEM | 121 UNIVERSITY HALL | COLUMBIA | MO | 65211-3020 | BOONE | USA | R37CA241603 | Membrane protein target for leukemia therapy | 000 | 5 | NIH | 7/12/2024 | $424,411 |
| 2024 | 2024 | UNIVERSITY OF MISSOURI SYSTEM | 121 UNIVERSITY HALL | COLUMBIA | MO | 65211-3020 | BOONE | USA | T34GM136493 | MARC at the University of Missouri-Columbia | 001 | 5 | NIH | 5/15/2024 | $190,096 |
| 2024 | 2024 | UNIVERSITY OF MISSOURI SYSTEM | 121 UNIVERSITY HALL | COLUMBIA | MO | 65211-3020 | BOONE | USA | R35GM136409 | Structure prediction and in silico screening of protein-peptide interactions | 000 | 5 | NIH | 5/8/2024 | $383,330 |
| 2024 | 2024 | UNIVERSITY OF MISSOURI SYSTEM | 121 UNIVERSITY HALL | COLUMBIA | MO | 65211-3020 | BOONE | USA | R01AA027824 | A Multi-Method Study of Extreme Alcohol Drinkers in the Lab and in Real-Life: Increasing Precision of Assessments of Extreme Drinking Determinants | 000 | 5 | NIH | 7/12/2024 | $482,037 |
| 2024 | 2024 | UNIVERSITY OF MISSOURI SYSTEM | 121 UNIVERSITY HALL | COLUMBIA | MO | 65211-3020 | BOONE | USA | 07CD004080 | Head Start State Collaboration Office | 00 | 4 | ACF | 2/9/2024 | $175,000 |
| 2024 | 2024 | UNIVERSITY OF MISSOURI SYSTEM | 121 UNIVERSITY HALL | COLUMBIA | MO | 65211-3020 | BOONE | USA | U01CA244314 | Human CD3epsilon co-potentiation to boost immunotherapy | 000 | 1 | NIH | 2/9/2024 | $34,643 |
| 2024 | 2024 | UNIVERSITY OF MISSOURI SYSTEM | 121 UNIVERSITY HALL | COLUMBIA | MO | 65211-3020 | BOONE | USA | T32GM135744 | IMSD: An Initiative to Maximize Student Development in Biomedical Research at MU | 002 | 5 | NIH | 5/17/2024 | $29,666 |
| 2024 | 2024 | UNIVERSITY OF MISSOURI SYSTEM | 121 UNIVERSITY HALL | COLUMBIA | MO | 65211-3020 | BOONE | USA | T32GM135744 | IMSD: An Initiative to Maximize Student Development in Biomedical Research at MU | 001 | 5 | NIH | 1/15/2024 | $474,723 |
| 2024 | 2024 | UNIVERSITY OF MISSOURI SYSTEM | 121 UNIVERSITY HALL | COLUMBIA | MO | 65211-3020 | BOONE | USA | R01AI152521 | Impact of repeated vaccination on the effectiveness of seasonal influenza vaccines | 001 | 4 | NIH | 5/24/2024 | $72,206 |
| 2024 | 2024 | UNIVERSITY OF MISSOURI SYSTEM | 121 UNIVERSITY HALL | COLUMBIA | MO | 65211-3020 | BOONE | USA | R01AI152521 | Impact of repeated vaccination on the effectiveness of seasonal influenza vaccines | 000 | 4 | NIH | 3/1/2024 | $649,855 |
| 2024 | 2024 | UNIVERSITY OF MISSOURI SYSTEM | 121 UNIVERSITY HALL | COLUMBIA | MO | 65211-3020 | BOONE | USA | R01CA252484 | Autoimmunity in Cardiopulmonary Toxicities from Radiotherapy andImmunotherapy | 000 | 5 | NIH | 5/22/2024 | $584,575 |
| 2024 | 2024 | UNIVERSITY OF MISSOURI SYSTEM | 121 UNIVERSITY HALL | COLUMBIA | MO | 65211-3020 | BOONE | USA | H79SM082871 | Central Missouri Child Trauma Initiative | 000 | 5 | SAMHSA | 3/7/2024 | $397,361 |
| 2024 | 2024 | UNIVERSITY OF MISSOURI SYSTEM | 121 UNIVERSITY HALL | COLUMBIA | MO | 65211-3020 | BOONE | USA | R01HL153523 | Sex disparities in hypoxic sympatholysis and impact of obesity | 002 | 5 | NIH | 7/18/2024 | $0 |
| 2024 | 2024 | UNIVERSITY OF MISSOURI SYSTEM | 121 UNIVERSITY HALL | COLUMBIA | MO | 65211-3020 | BOONE | USA | R01HL153523 | Sex disparities in hypoxic sympatholysis and impact of obesity | 000 | 5 | NIH | 6/19/2024 | $504,366 |
| 2024 | 2024 | UNIVERSITY OF MISSOURI SYSTEM | 121 UNIVERSITY HALL | COLUMBIA | MO | 65211-3020 | BOONE | USA | R01HL153523 | Sex disparities in hypoxic sympatholysis and impact of obesity | 001 | 5 | NIH | 6/21/2024 | $62,564 |
| 2024 | 2024 | UNIVERSITY OF MISSOURI SYSTEM | 121 UNIVERSITY HALL | COLUMBIA | MO | 65211-3020 | BOONE | USA | R01MH121345 | Neonatal Cry Acoustics and Neurobehavioral Characteristics as Early Markers of Risk for Autism Spectrum Disorder | 000 | 6 | NIH | 7/11/2024 | $579,470 |
| 2024 | 2024 | UNIVERSITY OF MISSOURI SYSTEM | 121 UNIVERSITY HALL | COLUMBIA | MO | 65211-3020 | BOONE | USA | R35GM134919 | New methods for computational modeling of RNA structures | 001 | 5 | NIH | 6/20/2024 | $49,667 |
| 2024 | 2024 | UNIVERSITY OF MISSOURI SYSTEM | 121 UNIVERSITY HALL | COLUMBIA | MO | 65211-3020 | BOONE | USA | U18FD006670 | FDA Vet-LIRN Site Application - Tier I Lab Renewal | 000 | 6 | FDA | 6/13/2024 | $39,900 |
| 2024 | 2024 | UNIVERSITY OF MISSOURI SYSTEM | 121 UNIVERSITY HALL | COLUMBIA | MO | 65211-3020 | BOONE | USA | R35GM134919 | New methods for computational modeling of RNA structures | 000 | 5 | NIH | 3/12/2024 | $447,007 |
| 2024 | 2024 | UNIVERSITY OF MISSOURI SYSTEM | 121 UNIVERSITY HALL | COLUMBIA | MO | 65211-3020 | BOONE | USA | R01AI147640 | Use of Clinical Samples to Identify Influenza Virus Antigenic Variants | 000 | 5 | NIH | 6/25/2024 | $553,124 |
| 2024 | 2024 | UNIVERSITY OF MISSOURI SYSTEM | 121 UNIVERSITY HALL | COLUMBIA | MO | 65211-3020 | BOONE | USA | K01HL142944 | Adaptation and implementation of a Cherokee-based participatory research project to reduce CVD risk | 000 | 5 | NIH | 2/1/2024 | $131,189 |
| 2024 | 2024 | UNIVERSITY OF MISSOURI SYSTEM | 121 UNIVERSITY HALL | COLUMBIA | MO | 65211-3020 | BOONE | USA | R01DK120595 | Vascular ion channels and microcirculation in neonatal urinary tract obstruction | 001 | 5 | NIH | 7/17/2024 | $491,984 |
| 2024 | 2024 | UNIVERSITY OF MISSOURI SYSTEM | 121 UNIVERSITY HALL | COLUMBIA | MO | 65211-3020 | BOONE | USA | R01AI162631 | Interplay between influenza virus and S1P-metabolizing enzymes | 000 | 4 | NIH | 6/25/2024 | $312,519 |
| 2024 | 2024 | UNIVERSITY OF MISSOURI SYSTEM | 121 UNIVERSITY HALL | COLUMBIA | MO | 65211-3020 | BOONE | USA | R01HD094937 | Modeling Normal and Abnormal Trophoblasts | 000 | 7 | NIH | 5/1/2024 | $551,269 |
| 2024 | 2024 | UNIVERSITY OF MISSOURI SYSTEM | 121 UNIVERSITY HALL | COLUMBIA | MO | 65211-3020 | BOONE | USA | R01HD094937 | Modeling Normal and Abnormal Trophoblasts | 001 | 7 | NIH | 5/6/2024 | $55,126 |
| 2024 | 2024 | UNIVERSITY OF MISSOURI SYSTEM | 121 UNIVERSITY HALL | COLUMBIA | MO | 65211-3020 | BOONE | USA | R35GM126985 | Multi-view self-supervised deep learning for biological sequences and beyond | 002 | 7 | NIH | 7/23/2024 | $391,250 |
| 2024 | 2024 | UNIVERSITY OF MISSOURI SYSTEM | 121 UNIVERSITY HALL | COLUMBIA | MO | 65211-3020 | BOONE | USA | R01GM121445 | DORN1 defines a new family of receptor kinase purinoreceptors (P2K) | 000 | 8 | NIH | 7/15/2024 | $328,650 |
| 2024 | 2024 | UNIVERSITY OF MISSOURI SYSTEM | 121 UNIVERSITY HALL | COLUMBIA | MO | 65211-3020 | BOONE | USA | R01HL136292 | Cardiomyocyte TRPV4 and Angiotensin-II induced ventricular arrhythmia with aging | 001 | 7 | NIH | 6/22/2024 | $32,832 |
|